More Risks Shown for Oral Diabetes Drugs

Commonly prescribed diabetes medications have been linked to risk of pancreatitis and pancreatic cancer, according to recent publications. The drugs include exenatide (Byetta), liraglutide (Victoza), sitagliptin (Januvia), and possibly other similar medications. Reports from Dr. Peter Butler of UCLA and Drs. Sonal Singh and Jodi Segal of Johns Hopkins University describe these adverse effects in the journals Gastroenterolgy, JAMA Internal Medicine, and Diabetes. These new warnings about adverse effects of oral diabetes medications follow in the wake of the FDA pulling blockbuster medications troglitazone (Rezulin) off the market, restricting use of rosiglitazone (Avandia), and issuing warnings related to bladder cancer to pioglitazone (Actos).

“Prevention and treatment of type 2 diabetes with nutritional measures, especially a plant-based diet and avoidance of meat and dairy products, remains a safe and effective approach,” says Dr. Neal Barnard of the Physicians Committee for Responsible Medicine.

 

Comments are closed.